β1-Integrin-A Key Player in Controlling Pancreatic Beta-Cell Insulin Secretion via Interplay With SNARE Proteins

Endocrinology. 2022 Nov 14;164(1):bqac179. doi: 10.1210/endocr/bqac179.

Abstract

Shortcomings in cell-based therapies for patients with diabetes have been revealed to be, in part, a result of an improper extracellular matrix (ECM) environment. In vivo, pancreatic islets are emersed in a diverse ECM that provides physical support and is crucial for healthy function. β1-Integrin receptors have been determined to be responsible for modulation of beneficial interactions with ECM proteins influencing beta-cell development, proliferation, maturation, and function. β1-Integrin signaling has been demonstrated to augment insulin secretion by impacting the actin cytoskeleton via activation of focal adhesion kinase and downstream signaling pathways. In other secretory cells, evidence of a bidirectional relationship between integrins and exocytotic machinery has been demonstrated, and, thus, this relationship could be present in pancreatic beta cells. In this review, we will discuss the role of ECM-β1-integrin interplay with exocytotic proteins in controlling pancreatic beta-cell insulin secretion through their dynamic and unique signaling pathway.

Keywords: FAK signaling; SNARE proteins; actin cytoskeleton; beta cell; insulin secretion; β1 integrin.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion / physiology
  • Humans
  • Insulin Secretion
  • Insulin-Secreting Cells* / metabolism
  • Integrin beta1 / metabolism
  • Integrins / metabolism
  • SNARE Proteins / metabolism

Substances

  • Integrin beta1
  • SNARE Proteins
  • Integrins